The association of N -palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action
Pre-publication versions of this article are available by contacting email@example.com.
|11 Oct 2011||Submitted||Original manuscript|
|8 Nov 2011||Reviewed||Reviewer Report - Virginia Seybold|
|11 Nov 2011||Reviewed||Reviewer Report - Vincenzo Di Marzo|
|17 Nov 2011||Reviewed||Reviewer Report - Natsuo Ueda|
|21 Nov 2011||Reviewed||Reviewer Report - Guillermo Velasco|
|14 Dec 2011||Author responded||Author comments - Didier Lambert|
|Resubmission - Version 2|
|14 Dec 2011||Submitted||Manuscript version 2|
|27 Dec 2011||Reviewed||Reviewer Report - Guillermo Velasco|
|2 Jan 2012||Reviewed||Reviewer Report - Vincenzo Di Marzo|
|6 Jan 2012||Reviewed||Reviewer Report - Virginia Seybold|
|17 Jan 2012||Author responded||Author comments - Didier Lambert|
|Resubmission - Version 3|
|17 Jan 2012||Submitted||Manuscript version 3|
|13 Feb 2012||Author responded||Author comments - Didier Lambert|
|Resubmission - Version 4|
|13 Feb 2012||Submitted||Manuscript version 4|
|19 Mar 2012||Editorially accepted|
|19 Mar 2012||Article published||10.1186/1471-2407-12-92|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.